🇺🇸 Midazolam Nasal Spray in United States

6 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 23 April 2025 – 23 April 2026
• Total reports: 6

Most-reported reactions

1. Cerebral Haemorrhage — 1 report (16.67%)
2. Encephalitis — 1 report (16.67%)
3. Generalised Tonic-Clonic Seizure — 1 report (16.67%)
4. Hypoaesthesia — 1 report (16.67%)
5. Seizure — 1 report (16.67%)
6. Treatment Failure — 1 report (16.67%)

Source database →

Frequently asked questions

Is Midazolam Nasal Spray approved in United States?

Midazolam Nasal Spray does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Midazolam Nasal Spray in United States?

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's is the originator. The local marketing authorisation holder may differ — check the official source linked above.